Oxazepam is a benzodiazepine used extensively since the 1960’s for the treatment of anxiety and insomnia and in the control of symptoms of alcohol withdrawal.
There is inadequate evidence in humans for the carcinogenicity of Oxazepam but there is sufficient evidence in experimental animals for the carcinogenicity of Oxazepam. As such the overall conclusion is that Oxazepam is possibly carcinogenic to humans (Group 2B).
In support of the “No Time to Lose” Campaign the SEL Group will be running an “Alphabet of Carcinogens” campaign and each week we shall release details regarding a different well known carcinogen.
For reference or further information on Oxazepam visit:
